AM251,, > 98 %( HPLC), solide

Code: A6226-50MG D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

AM251, a CB1 cannabinoid receptor antagonist, has been used in a study to determine its interaction with hippocampal neurons to enhance spatial memory ...


 En savoir plus

Votre prix
$1,103.88 50MG
DEMANDER

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

AM251, a CB1 cannabinoid receptor antagonist, has been used in a study to determine its interaction with hippocampal neurons to enhance spatial memory in mice.

Biochem/physiol Actions

AM251 is a CB1 cannabinoid receptor antagonist.

Features and Benefits

This compound is featured on the Cannabinoid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Other Notes

Salt content may vary.

Packaging

10, 50 mg in glass bottle

assay>98% (HPLC)
colorwhite
formsolid
Gene Informationmouse ... Cnr1(12801), Cnr2(12802)rat ... Cnr1(25248)
InChI keyBUZAJRPLUGXRAB-UHFFFAOYSA-N
InChI1S/C22H21Cl2IN4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-7-16(23)13-18(19)24)21(14)15-5-8-17(25)9-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)
originatorSanofi Aventis
Quality Level100
SMILES stringCc1c(nn(-c2ccc(Cl)cc2Cl)c1-c3ccc(I)cc3)C(=O)NN4CCCCC4
solubilityDMSO: >10 mg/mL, H2O: insoluble
Cas Number183232-66-8
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN
GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.